Ann Hynes
Stock Analyst at Mizuho
(4.22)
# 414
Out of 5,157 analysts
285
Total ratings
62.44%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $12.95 | +31.27% | 5 | Mar 5, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $45 → $50 | $41.34 | +20.95% | 4 | Mar 3, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $537.64 | +8.81% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $167.37 | +4.56% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $200.90 | +16.97% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $282.34 | +23.96% | 22 | Feb 5, 2026 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $11 → $13 | $8.95 | +45.25% | 6 | Dec 18, 2025 | |
| ARDT Ardent Health | Maintains: Outperform | $20 → $12 | $9.04 | +32.74% | 4 | Dec 18, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $25.14 | -32.38% | 13 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Outperform | $88 → $95 | $76.32 | +24.48% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $420 → $400 | $282.68 | +41.50% | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $466.79 | +40.32% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $194 → $225 | $237.42 | -5.23% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $268.70 | +19.09% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $173.62 | +98.71% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $28 → $40 | $36.40 | +9.89% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $170.93 | +31.63% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $106.62 | +111.03% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $330 | $141.32 | +133.51% | 9 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $19.74 | -24.01% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $217.04 | -44.71% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $22.44 | +24.78% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $106.89 | -11.12% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $262.44 | +46.70% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $186.53 | +7.22% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.41 | +18,907.09% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $928.69 | -45.62% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.81 | +6,908.48% | 1 | Sep 21, 2017 |
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $12.95
Upside: +31.27%
BrightSpring Health Services
Mar 3, 2026
Maintains: Outperform
Price Target: $45 → $50
Current: $41.34
Upside: +20.95%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $537.64
Upside: +8.81%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $167.37
Upside: +4.56%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $200.90
Upside: +16.97%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $282.34
Upside: +23.96%
Fortrea Holdings
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $8.95
Upside: +45.25%
Ardent Health
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $9.04
Upside: +32.74%
Acadia Healthcare Company
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $25.14
Upside: -32.38%
CVS Health
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $76.32
Upside: +24.48%
Nov 4, 2025
Maintains: Outperform
Price Target: $420 → $400
Current: $282.68
Upside: +41.50%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $466.79
Upside: +40.32%
Oct 17, 2025
Maintains: Outperform
Price Target: $194 → $225
Current: $237.42
Upside: -5.23%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $268.70
Upside: +19.09%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $173.62
Upside: +98.71%
Oct 9, 2025
Maintains: Neutral
Price Target: $28 → $40
Current: $36.40
Upside: +9.89%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $170.93
Upside: +31.63%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $106.62
Upside: +111.03%
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $141.32
Upside: +133.51%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $19.74
Upside: -24.01%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $217.04
Upside: -44.71%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.44
Upside: +24.78%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $106.89
Upside: -11.12%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $262.44
Upside: +46.70%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $186.53
Upside: +7.22%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.41
Upside: +18,907.09%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $928.69
Upside: -45.62%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.81
Upside: +6,908.48%